Red Light Nasal Therapy Device + RespicoviX

• Light wavelength: 630 nm ± 20 nm (red light)
• Radiation intensity: 12 mW ± 3 mW
• Technology: low-intensity photobiological red light therapy
• Integrated program: RespicoviX biopattern program
• Power supply: rechargeable / USB
• Application area: nasal cavity and surrounding sinus regions
• Recommended use: 1–2 times per day for 10–15 minutes

Red Light Nasal Therapy Device + RespicoviX – an innovative, non-invasive solution designed to support nasal and respiratory system wellness by combining low-intensity red light therapy with the integrated BioMind RespiCoviX biopattern program. This combination provides a gentle, pleasant effect that helps you feel more comfortable during respiratory imbalance.

The device emits precise wavelength light – 630 nm ± 20 nm, with a radiation intensity of 12 mW ± 3 mW. Red light photons penetrate the nasal mucosa and are absorbed by mitochondria within the cells. This wavelength range is associated in scientific literature with ATP (adenosine triphosphate) production processes in cells. This may contribute to a more pleasant breathing sensation and general nasal mucosa wellbeing.

The integrated BioMind RespicoviX program operates on an informational–energetic level, harmonizing the vibrational patterns of the nasal and respiratory systems. These biopatterns are designed to support respiratory energetic balance, helping you naturally feel lighter and more comfortable.

This is a different, gentle technology, based on light and frequency resonance. Regular use may contribute to overall nasal area wellbeing and a more pleasant breathing sensation.

To better understand the product's mechanism, it is recommended to complete the Radionics seminar.

This product is not a medical device – it is intended for supplementary wellness use. It belongs to the category of beauty and well-being enhancement tools. It is not intended to diagnose, treat, cure, or prevent any health conditions. If you have any health concerns, consult your doctor or another qualified healthcare professional before use.

Before use, make sure the device is fully charged. Gently insert the light applicators into the nostrils so that they fit comfortably against the mucosa.

• Turn on the device and allow the therapy to run for 10–15 minutes.
• The procedure can be repeated 1–2 times per day, depending on need or symptom intensity.
• It is recommended to use it in the morning (for sinus decongestion) and in the evening (for mucosal regeneration and relaxation).
• During therapy, it is advisable to breathe calmly and deeply to improve oxygen absorption and relax the nasal muscles.
• After use, clean the applicators with a disinfectant wipe or a clean cloth.

Regular use may contribute to overall nasal area wellbeing and a more pleasant breathing sensation.

Helps support respiratory comfort:

• A more pleasant breathing sensation
• Support for nasal mucosa wellbeing
• A sense of improved circulation in the area
• Overall cellular wellbeing and mucosal comfort
• Relaxation and energetic balance through photobiological effects

What the scientific literature shows about nasal mucosa light therapy (in general, not about this specific product):

• Several randomized, placebo-controlled clinical trials and systematic reviews (see references below) show that intranasal red/near-infrared light therapy is associated with symptom reduction in people with allergic rhinitis.
• A meta-analysis also shows a positive effect for chronic rhinosinusitis.

Important: This device emits light in a similar wavelength range to the devices used in these studies. However, this specific product has not been separately clinically tested and does not carry medical certification or regulatory clearance. The information above summarizes the general scientific literature on this technology as a whole – it is not a claim that this specific device diagnoses or treats any condition.

References:

• “Low-Level Laser Therapy for Allergic Rhinitis: A Systematic Review and Meta-Analysis” — PMCID: PMC11370728
• “The effectiveness of low-level laser therapy for chronic rhinosinusitis: A systematic review and meta-analysis” — PMID: 41239066
• “Efficacy of Using Photobiomodulation Therapy in Allergic Rhinitis: A Placebo-Controlled Randomized Clinical Trial” — PMID: 39828891
• “Effect of Red Light Rhinophototherapy on Nasal Patency in Patients with Allergic Rhinitis” — PMCID: PMC6311790